hotspot -WSS

hotspot

author：hotspot 2025-09-28 21:56:37 - browse：676

The Novartis booth at ESMO in Madrid. — The Novartis booth at ESMO 2023 in Madrid. Andrew Joseph/STAT

MADRID — Results presented Monday could expand the use of a Novartis therapy for metastatic prostate cancer, moving it from a treatment used after chemotherapy to one with demonstrated benefits beforehand as well.

The Phase 3 data, highlighted in a prime session here at the annual meeting of the European Society for Medical Oncology, also amount to another win for cancer therapies designed to deliver radiation directly to tumor cells. It’s a field that Novartis has poured investments into, and that is attracting interest from other pharma companies.

The trial, called PSMAfore, enrolled patients with a type of metastatic prostate cancer whose disease had started to progress after taking a drug known as an androgen receptor pathway inhibitor, or ARPI. Patients were randomized to either receive a different ARPI or Novartis’ therapy, Pluvicto.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： KalVista pill reduced swelling 'attacks' caused by genetic disease

knowledge

WSS

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

BioAge raises $170M for combination therapy with Zepbound

Southern California school board OKs curriculum after Gov. Gavin Newsom threatened a $1.5M fine

'Revelatory' study finds a smoking impact that remains after quitting

Readout LOUD podcast: How biotech is using artificial intelligence

Vaccine advisory panel ACIP left half staffed by HHS

focus

hotspot

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

Artificial intelligence advances fuel industry trying to preserve loved ones after death

At least 13 dead in Texas as scorching temps continue

Why did Pfizer dish out millions for a Super Bowl ad?

What does generative AI mean for health care? We asked experts

Review: 'Barbie' will hit you like a shot in the heart

Medicare details structure of new drug price negotiation program

Private equity deals in Medicare Advantage declines

BioMarin wins approval for gene therapy to treat hemophilia A

Body of missing toddler recovered in Delaware River days after flood: Police

hotspot

Why an extreme heat and wildfire smoke combination can be so dangerous

How artificial intelligence is being used to detect, treat cancer

Organ transplantation is at a crossroads. Major reform is needed

Contact tracing may help avoid another lockdown. Can it work in the U.S.?

What should King Charles tell the public about his cancer?

Medicare threatens to cut off funding for HCA's Mission hospital

focus

knowledge

hotspot

focus